As of 2025-10-30, the Relative Valuation of Poseida Therapeutics, Inc. (PSTX) is (5.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.50 USD, the upside of Poseida Therapeutics, Inc. based on Relative Valuation is -162.5%.
The range of the Relative Valuation is (4.46) - (7.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.8x - 12.8x | 8.8x |
| Forward P/E multiples | 7.2x - 13.3x | 10.2x |
| Fair Price | (4.46) - (7.99) | (5.94) |
| Upside | -147.0% - -184.1% | -162.5% |
| Date | P/E |